In a report released today, Adam Cochrane from Deutsche Bank maintained a Hold rating on PUMA SE NPV, with a price target of €20.00. The company’s shares closed last Tuesday at $25.03.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Cochrane covers the Consumer Cyclical sector, focusing on stocks such as PUMA SE NPV, adidas AG, and H&M Hennes & Mauritz AB Class B. According to TipRanks, Cochrane has an average return of -5.3% and a 36.25% success rate on recommended stocks.
The word on The Street in general, suggests a Hold analyst consensus rating for PUMA SE NPV with a $27.66 average price target, implying a 10.53% upside from current levels. In a report released today, Barclays also maintained a Hold rating on the stock with a €19.00 price target.
Based on PUMA SE NPV’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $2.08 billion and a net profit of $500 thousand. In comparison, last year the company earned a revenue of $2.1 billion and had a net profit of $87.3 million
Based on the recent corporate insider activity of 8 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of PMMAF in relation to earlier this year.
Read More on PMMAF:
Disclaimer & DisclosureReport an Issue
- Puma’s Strategic Turnaround: A Buy Rating Amidst Brand Cycle Reset and Valuation Opportunities
- Puma upgraded to Neutral from Underperform at BNP Paribas Exane
- Puma Positioned for Growth: Buy Rating Amid Brand Cycle Opportunities and Strategic Leadership
- Puma downgraded to Neutral from Buy at Rothschild & Co Redburn
- Puma initiated with an Outperform at Bernstein